Analytical Data
-
基因名
OP
- Application
-
别名
Antifreeze protein lambda OP-3
-
种属
Zoarces americanus
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P19606
-
表达区间
23-91aa
-
分子量
11.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
OP (Oligomeric Protein) recombinant proteins have garnered significant attention in recent years due to their potential applications in biotechnology and medicine. These proteins, which are produced through recombinant DNA technology, allow for the study and manipulation of complex biological functions, paving the way for advancements in various fields such as drug development, vaccine production, and therapeutic interventions. Research on OP recombinant proteins focuses on understanding their structure, function, and interactions within cellular environments. By harnessing the capabilities of genetic engineering, scientists can create specific protein variants that exhibit desired properties, such as increased stability, enhanced activity, or improved binding affinities. This has profound implications for drug design, particularly in the development of targeted therapies for diseases like cancer, where precise molecular interactions are crucial. Additionally, the ability to produce these proteins in large quantities provides a sustainable and efficient means of generating essential biological materials needed for research and treatment. Overall, the ongoing exploration of OP recombinant proteins stands at the intersection of molecular biology and therapeutic innovation, driving forward the potential for groundbreaking solutions to pressing health challenges.
